Everything below concerns Heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
Common degradation pathways include oxidation of the methionine side chain, hydrolysis of the peptide backbone, and aggregation under unfavourable pH or concentration. Stability studies typically monitor the main peak by chromatography and report total related substances as a percentage. Because no official monograph exists, acceptance criteria vary between laboratories, and reported purity values are not directly comparable across suppliers. Analysts therefore document the method, column, and detection wavelength alongside each result, and open questions remain about how much biological activity the oxidised forms retain.
Solid semax is typically supplied as a lyophilised powder that is hygroscopic and sensitive to moisture, light, and repeated temperature cycling. Long-term storage of the dry peptide is generally recommended at approximately -20 degrees Celsius, while shorter working periods may use refrigeration at 2 to 8 degrees Celsius. Vials should remain tightly closed and desiccated when brought to room temperature, because condensation can damage the material before it is weighed. Dividing a batch into aliquots is preferable to thawing one container repeatedly.
Dissolution is normally performed in water, phosphate-buffered saline, or normal saline, since the peptide is freely soluble in aqueous media and is rarely handled with strong organic solvents. Solution pH should be kept near neutral, because extreme acidity or alkalinity accelerates backbone hydrolysis and encourages oxidation of the methionine side chain. Once dissolved, the material is less stable than the dry powder and is commonly divided into single-use portions and frozen. Buffers containing primary amines, such as Tris, are often avoided because of possible side reactions.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.
| Property | Value | Notes |
|---|---|---|
| Typical analytical method | Reversed-phase HPLC with UV detection | Separates target peptide from truncated and oxidised forms |
| Identity confirmation | LC-MS or ESI-MS | Compares observed and calculated molecular ion |
| Primary degradation route | Methionine oxidation | Forms the sulfoxide; monitored as an early-eluting peak |
| Short-term storage | 2 to 8 degrees Celsius | Applies to working vials and reconstituted portions |
| Common synonyms | ACTH(4–10) analogue, MEHFPGP | Descriptive names used in laboratory catalogues |
Identity and purity of Semax are established mainly by reversed-phase high-performance liquid chromatography coupled with mass spectrometry. The chromatographic trace gives a purity estimate as a percentage of total peak area, while electrospray or matrix-assisted laser desorption ionization confirms the molecular mass against the calculated value. Amino acid analysis and sequence-specific fragmentation provide further confirmation when a supplier's chain of custody is unclear. Vendors frequently quote a purity figure without stating the detection wavelength or the integration method, which limits how far one number can be compared with another.
Stability depends heavily on physical state. Lyophilized powder held dry, cold and dark retains its content over long periods, whereas dissolved peptide begins to change within days at room temperature. The most cited degradation route is oxidation of the methionine residue, which converts the peptide to a sulfoxide form that elutes differently on chromatography. Hydrolysis of amide bonds and adsorption onto container walls contribute smaller losses. Buffers that exclude oxygen from the headspace slow the oxidation pathway, but no single condition prevents all change indefinitely.
Practical handling follows from those properties. Bulk material is best divided into single-use portions soon after receipt, because each thaw exposes the whole container to moisture and temperature cycling. Vials should be allowed to reach room temperature before opening to prevent condensation on the powder. Low-binding plasticware reduces loss of dilute solutions, and sterile filtration is used when a preparation must remain free of microbial growth. Records of batch number, reconstitution date and storage history are what allow a later analytical result to be interpreted meaningfully.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, with ultraviolet detection near 214 nanometers for the peptide backbone. Mass spectrometry, either electrospray or matrix-assisted laser desorption, confirms molecular mass and detects truncation or modification products. Amino acid analysis can verify composition. Because the sequence contains no strongly absorbing aromatic residue apart from phenylalanine, detection wavelengths are chosen carefully. Purity values above 95 percent are typical for research-grade material.
== Further reading == Farris, Glenn J. (1982). "Pine Nuts as an Aboriginal Food Source in California and Nevada: Some Contrasts" (PDF). Journal of Ethnobiology. 2 (2): 114–122. Farris GJ, Blackburn, TC, Anderson K (1993). "Quality Food: The Quest for Pine Nuts in Northern California". Before the Wilderness: Environmental Management by Native Californians. Ballena Press. pp. 229–240.
=== Genetics === Several genetic loci have been identified as associated with insulin insensitivity. These include variations in loci near the NAT2, GCKR, and IGFI genes, which are linked to insulin resistance. Further research has indicated that loci near these genes are correlated with insulin resistance. However, it is estimated that these loci only account for 25–44% of the genetic component of insulin resistance.
== Plot == As the Federation Starship Enterprise approaches the planet Omega IV, the USS Exeter is found orbiting it. Captain Kirk, First Officer Spock, Dr. McCoy and Lt. Galloway beam over to the Exeter to investigate. They find the ship deserted, save for a few uniforms that are covered with a crystalline substance found to be human remains. The ship's logs reveal that the Exeter's crew died from an infectious disease that had been brought from the planet, and that Enterprise's landing party is now infected and must beam down to the planet if they are to survive. Kirk's party beams down to the last coordinates stored in the Exeter's computer. There, they discover Exeter Captain Ron Tracey (Morgan Woodward). Tracey explains that he had been on the planet when the disease had ravaged his ship, stranding him. He says he has discovered that remaining on the planet confers immunity to the disease. He then reveals that the villagers he is living with on the planet, known as "Kohms", are at war with "savages" called "Yangs". After a Yang attack, Spock investigates the field of battle and finds evidence that Tracey has been helping the Kohms, in violation of the Prime Directive. Kirk tries to contact the Enterprise, but is prevented by Tracey, who tries to justify his violation by revealing that the planet’s natives are not only immune to the mysterious disease, but have also developed lifespans of over 1000 years. Tracey orders McCoy to investigate the secret of their longevity and has Kirk and Spock locked up in a crude jail with two Yang prisoners, one male and one female.
This can happen, for example, when a recombinant DNA fragment containing an active promoter becomes located next to a previously silent host cell gene, or when a host cell gene that functions to restrain gene expression undergoes insertional inactivation by recombinant DNA.
Sources: en.wikipedia.org
Art and culture became strictly regulated under the principles of socialist realism and Russian traditions that Stalin admired were allowed to continue. Foreign policy in the Soviet Union from 1929 to 1941 resulted in substantial changes in the Soviet Union's approach to its foreign policy. In 1933, the Marxist–Leninist geopolitical perspective was that the Soviet Union was surrounded by capitalist and anti-communist enemies. As a result, the election of Adolf Hitler and his Nazi Party government in Germany initially caused the Soviet Union to sever diplomatic relations that had been established in the 1920s. In 1938, Stalin accommodated the Nazis and the anti-communist West by not defending Czechoslovakia, allowing Hitler's threat of pre-emptive war for the Sudetenland to annex the land and "rescue the oppressed German peoples" living in Czecho. To challenge Nazi Germany's bid for European empire and hegemony, Stalin promoted anti-fascist front organisations to encourage European socialists and democrats to join the Soviet communists to fight throughout Nazi-occupied Europe, creating agreements with France to challenge Germany. After Germany and Britain signed the Munich Agreement (29 September 1938) which allowed the German occupation of Czechoslovakia (1938–1945), Stalin adopted pro-German policies for the Soviet Union's dealings with Nazi Germany.
Rita Levi-Montalcini and Stanley Cohen discovered NGF in the 1950s while faculty members at Washington University in St. Louis, for which they were awarded a Nobel Prize in Physiology or Medicine in 1986. The critical preliminary discovery was done by Levi-Montalcini and Hertha Meyer at the Carlos Chagas Filho Biophysics Institute of the Federal University of Rio de Janeiro in 1952. Their publication in 1954 became the definitive proof for the existence of the protein. Levi-Montalcini later remarked:The tumor had given a first hint of its existence in St. Louis but it was in Rio de Janeiro that it revealed itself, and it did so in a theatrical and grand way, as if spurred by the bright atmosphere of that explosive and exhuberant manifestation of life that is the Carnival in Rio.However, its discovery, along with the discovery of other neurotrophins, was not widely recognized until 1986, when it won the Nobel Prize in Physiology or Medicine. Studies in 1971 determined the primary structure of NGF. This eventually led to the discovery of the NGF gene. NGF is abundant in seminal plasma. Recent studies have found that it induces ovulation in some mammals. Nerve Growth Factors (NGF) were initially discovered due to their actions during development, but NGF are now known to be involved in the function throughout the life of the animal.
The spray is a combination of local anaesthetics lidocaine and prilocaine in a metered-dose aerosol that is sprayed directly on the penis to numb sensations. It was developed by the same group that invented the erectile dysfunction drug sildenafil. The drug was approved in Europe and was released in the UK market in November 2016 and within the EU will be marketed by, early in 2017 In the United States, the Food and Drug Administration (FDA) is expected to approve the drug in 2018.
Sources: en.wikipedia.org
== External links == Psilocybin - Isomer Design Psilocin - PsychonautWiki Psilocybin mushrooms - PsychonautWiki Psilocybin & Psilocin - Erowid 4-HO-DMT (Psilocybin) - TiHKAL - Erowid 4-HO-DMT (Psilocybin) - TiHKAL - Isomer Design The Big & Dandy 4-HO-DMT Thread - Bluelight Psilocybin Investigator's Brochure, Version 4.1 (2021) - Usona Institute
Esterification of L-glutamic acid [56-86-0] (1) with ethanol gives Glutamic acid diethyl ester [16450-41-2] (2). Lactam formation occurs on heating to give L-Pyroglutamic acid ethyl ester [7149-65-7] (3). The reduction of the ester with sodium borohydride gives L-Pyroglutaminol [17342-08-4] (4). Treatment with methyl chloride gave (S)-(5-Oxopyrrolidin-2-yl)methyl methanesulfonate [93288-20-1] (5). Displacement of the leaving group with cyanide led to (S)-5-Oxo-2-pyrrolidineacetonitrile [72479-06-2] (6). Catalytic reduction over Rosenmund catalyst in the presence of dimethylamine led to (5S)-5-[2-(dimethylamino)ethyl]pyrrolidin-2-one, PC13306712 (7). Oxidation in the presence of hydrogen peroxide formed the N-oxide (8). Elimination of the amino group in the presence of weak base led to (S)-5-Vinylpyrrolidin-2-one [93288-23-4] (9). Alkylation of the amino group with 2-Chlorobenzyl chloride [611-19-8] (10) in the presence of sodium hydride base led to (5S)-1-[(2-chlorophenyl)methyl]-5-ethenylpyrrolidin-2-one, PC56976994 (11). Treatment of the vinyl group with peroxy acid gave the oxirane. (5S)-1-[(2-chlorophenyl)methyl]-5-(oxiran-2-yl)pyrrolidin-2-one, PC88496451 (12). Treatment with (2R)-N-[(2R)-butan-2-yl]butan-2-amine, PC6347588 (13) completed the synthesis of Z4349 (14).
To solve this problem, contrast agents with disulfide, reversible bond between metal chelate and transduction moiety enhance the cell-associated retention. The disulfide bond is reduced by the target cell environment and the metal chelate remains trapped in the cytoplasm, increasing the retention time of chelate in the target cell.
Sources: en.wikipedia.org
Dry powder is usually kept at about -20 degrees Celsius for long-term storage and at 2 to 8 degrees Celsius for short working periods. Containers should stay sealed and protected from light and moisture to limit degradation.
Oxidation of the methionine residue to the sulfoxide is a frequently reported change, and it usually appears as an earlier-eluting peak in reversed-phase chromatography. Backbone hydrolysis products can also accumulate in aqueous solution.
Liquid chromatography coupled with mass spectrometry is the usual approach, because the observed molecular ion can be compared with a calculated mass of about 813.9 Da. Retention time alone does not establish identity.
Semax is based on the ACTH(4-10) fragment, a seven-amino-acid segment of adrenocorticotropic hormone. The synthetic peptide retains the core sequence while removing regions associated with endocrine activity. This modification is intended to isolate effects on the nervous system.